Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to -$0.05.

  • Rockwell Medical's EPS (Basic) fell 20000.0% to -$0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.18, marking a year-over-year decrease of 26000.0%. This contributed to the annual value of -$0.02 for FY2024, which is 9517.91% up from last year.
  • Rockwell Medical's EPS (Basic) amounted to -$0.05 in Q3 2025, which was down 20000.0% from -$0.05 recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's EPS (Basic) registered a high of $0.05 during Q3 2024, and its lowest value of -$1.04 during Q4 2021.
  • Its 5-year average for EPS (Basic) is -$0.31, with a median of -$0.07 in 2023.
  • In the last 5 years, Rockwell Medical's EPS (Basic) tumbled by 105555.56% in 2021 and then surged by 17142.86% in 2024.
  • Rockwell Medical's EPS (Basic) (Quarter) stood at -$1.04 in 2021, then soared by 95.19% to -$0.05 in 2022, then increased by 0.0% to -$0.05 in 2023, then skyrocketed by 49.84% to -$0.03 in 2024, then crashed by 99.35% to -$0.05 in 2025.
  • Its last three reported values are -$0.05 in Q3 2025, -$0.05 for Q2 2025, and -$0.04 during Q1 2025.